Tenecteplase in Patients With COVID-19
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Tenecteplase in Patients With COVID-19 is a clinical trial[1].
Key Facts
- Tenecteplase in Patients With COVID-19 is in the country of United States[2].
- Tenecteplase in Patients With COVID-19's instance of is recorded as clinical trial[3].
- Tenecteplase in Patients With COVID-19's start time is recorded as +2020-08-31T00:00:00Z[4].
- Tenecteplase in Patients With COVID-19's end time is recorded as +2021-02-28T00:00:00Z[5].
- Tenecteplase in Patients With COVID-19's contributor to the creative work or subject is recorded as Genentech[6].
- Tenecteplase in Patients With COVID-19's sponsor is recorded as Genentech[7].
- Tenecteplase in Patients With COVID-19's sponsor is recorded as Icahn School of Medicine at Mount Sinai[8].
- Tenecteplase in Patients With COVID-19's main subject is recorded as tenecteplase[9].
- Tenecteplase in Patients With COVID-19's number of participants is recorded as {'unit': '1', 'amount': '+60'}[10].
- Tenecteplase in Patients With COVID-19's title is recorded as Tenecteplase With Concomitant Anticoagulation for Severe Acute Respiratory Failure in Patients With COVID-19[11].
- Tenecteplase in Patients With COVID-19's uses is recorded as partial thromboplastin time[12].
- Tenecteplase in Patients With COVID-19's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Tenecteplase in Patients With COVID-19's ClinicalTrials.gov ID is recorded as NCT04505592[14].
- Tenecteplase in Patients With COVID-19's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[15].
- Tenecteplase in Patients With COVID-19's research intervention is recorded as tenecteplase[16].
- Tenecteplase in Patients With COVID-19's clinical trial phase is recorded as phase II clinical trial[17].
- Tenecteplase in Patients With COVID-19's research site is recorded as Mount Sinai Hospital[18].
- Tenecteplase in Patients With COVID-19's research subject recruitment status is recorded as not yet recruiting[19].
- Tenecteplase in Patients With COVID-19's study type is recorded as interventional study[20].